Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Scancell Holdings (SCLP) Share Price

Price 22.25p on 09-06-2026 at 18:35:12
Change 0.50p 2.3%
Buy 22.50p
Sell 22.00p
Last Trade: Buy 5,000.00 at 22.365p
Day's Volume: 902,491
Last Close: 22.25p
Open: 21.75p
ISIN: GB00B63D3314
Day's Range 21.75p - 22.25p
52wk Range: 7.90p - 27.80p
Market Capitalisation: £230.91m
VWAP: 22.04368p
Shares in Issue: 1.04b

Scancell Holdings (SCLP) Latest Trades

Buy/Sell Volume Trade Prc Trade Type Trade Time
Buy* 5,000 22.365p Ordinary
16:26:41 - 09-Jun-26
Buy* 2,361 22.40p Ordinary
16:10:58 - 09-Jun-26
Buy* 875 22.40p Ordinary
16:05:27 - 09-Jun-26
Buy* 23,080 22.365p Ordinary
15:57:04 - 09-Jun-26
Unknown* 170,000 22.50p Ordinary
15:55:25 - 09-Jun-26
Unknown* 100,000 22.25p Ordinary
15:55:14 - 09-Jun-26
Buy* 15,000 22.40p Ordinary
15:53:49 - 09-Jun-26
Buy* 518 22.40p Ordinary
15:44:04 - 09-Jun-26
Unknown* 5,000 22.25p Ordinary
15:21:33 - 09-Jun-26
Buy* 22,305 22.385p Ordinary
15:20:45 - 09-Jun-26
See more Scancell Holdings trades

Scancell Holdings (SCLP) Share Price History

Time period:
to
Date Open High Low Close Volume
8th Jun 2026 (Mon) 22.50 22.25 21.50 21.75 1,925,163
5th Jun 2026 (Fri) 22.75 22.60 22.60 22.60 708,467
4th Jun 2026 (Thu) 23.00 22.50 22.50 22.50 418,329
3rd Jun 2026 (Wed) 23.75 23.75 22.50 23.00 1,580,232
2nd Jun 2026 (Tue) 24.50 24.50 23.75 23.75 1,195,745
1st Jun 2026 (Mon) 24.00 24.75 24.00 24.50 1,928,027
29th May 2026 (Fri) 24.50 24.50 23.90 23.90 1,074,436
28th May 2026 (Thu) 24.50 24.50 23.75 24.50 1,298,230
27th May 2026 (Wed) 23.00 24.75 23.00 24.50 2,588,324
26th May 2026 (Tue) 22.00 23.25 22.00 23.00 1,485,525
25th May 2026 (Mon) 22.00 22.00 22.00 22.00 0
22nd May 2026 (Fri) 21.00 22.60 22.00 22.00 1,545,941
21st May 2026 (Thu) 20.50 21.60 21.00 21.00 4,252,809
20th May 2026 (Wed) 26.50 26.50 20.25 20.50 12,503,840
19th May 2026 (Tue) 25.25 27.80 25.00 26.50 11,299,996
18th May 2026 (Mon) 22.50 25.00 22.50 25.00 8,432,841
15th May 2026 (Fri) 21.00 22.75 21.50 22.75 3,976,208
14th May 2026 (Thu) 20.25 21.50 20.80 21.00 4,397,659
13th May 2026 (Wed) 18.25 20.25 18.90 20.00 2,140,991
12th May 2026 (Tue) 18.50 19.00 18.25 18.50 1,328,577
11th May 2026 (Mon) 17.00 19.25 17.20 19.00 3,529,558
See more Scancell Holdings price history

Scancell Holdings (SCLP) Regulatory News

Date Source Headline
28th Apr 2026 7:00 am RNS FDA Fast Track Designation for iSCIB1+
2nd Apr 2026 7:00 am RNS Scancell announces CFO transition
29th Jan 2026 7:00 am RNS Half-year Financial Report
26th Jan 2026 7:00 am RNS FDA clearance of IND application for iSCIB1+
22nd Jan 2026 7:00 am RNS Notice of Results
9th Dec 2025 7:00 am RNS Continued improvement in PFS with iSCIB1+
7th Nov 2025 7:00 am RNS Research Update
30th Oct 2025 3:30 pm RNS Result of AGM
3rd Oct 2025 7:00 am RNS Notice of AGM
16th Sep 2025 7:00 am RNS Director Dealing
See more Scancell Holdings regulatory news

Scancell Holdings (SCLP) Share News

WINNERS & LOSERS: Indonesia curbs hit MP Evans; S&U rises

20th May 2026 10:00

(Alliance News) - The following are the leading risers and fallers among London Main Market small-cap and AIM stocks on Wednesday. Read More

TRADING UPDATES: Conduit CFO Whelan to step down in September

28th Apr 2026 17:19

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Monday and not separately reported by Alliance News: Read More

IN BRIEF: Scancell names David Schilansky as interim finance chief

2nd Apr 2026 14:28

Scancell Holdings PLC - Oxford-based pharmaceutical company focused on cancer immunotherapies - Appoints "highly experienced senior healthcare executive and entrepreneur" David Schilansky, effective immediately, as a financial advisor. Says he will also become interim chief financial officer "later in April". Adds that it has launched a global recruitment process for a permanent successor to current CFO Sath Nirmalananthan, who is leaving Scancell and stepping down from the board with effect from April 24, "to pursue other professional opportunities." Scancell says Schilansky is currently concluding his role as chief executive officer of Ariceum Therapeutics, and starting as a venture partner and entrepreneur-in-residence at Redmile Group. Read More

EARNINGS AND TRADING: Pinewood Tech gets bid approach from Apax

29th Jan 2026 22:00

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Thursday and not separately reported by Alliance News: Read More

EARNINGS AND TRADING: Scancell gets FDA clearance for phase 3 trial

26th Jan 2026 19:18

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Monday and not separately reported by Alliance News: Read More

See more Scancell Holdings news
FTSE 100 Latest
Value10,227.33
Change-145.87

Login to your account

Forgot Password?

Not Registered